R Drews

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint Emerging treatment options for advanced-stage mycosis fungoides
    Reed E Drews
    Beth Israel Deaconess Medical Center, 330 Brookline Ave, E RA 430, Boston, MA 02215
    J Clin Oncol 30:4064-70. 2012
  2. ncbi request reprint Genetic analysis of adenovirus E1A: induction of genetic instability and altered cell morphologic and growth characteristics are segregatable functions
    R Drews
    Charles A Dana Research Institute and the Harvard Thorndike Laboratory of Beth Israel Deaconess Medical Center, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Mutat Res 421:9-25. 1998
  3. ncbi request reprint Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients
    Reed E Drews
    Department of Medicine, Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
    Clin Chest Med 24:607-22. 2003
  4. ncbi request reprint SMARCAD1, a novel human helicase family-defining member associated with genetic instability: cloning, expression, and mapping to 4q22-q23, a band rich in breakpoints and deletion mutants involved in several human diseases
    C N Adra
    Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Genomics 69:162-73. 2000
  5. pmc Disparities in breast cancer treatment and survival for women with disabilities
    Ellen P McCarthy
    Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Ann Intern Med 145:637-45. 2006
  6. pmc Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare
    Ellen P McCarthy
    Division of General Medicine and Primary Care, Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, E RO 139, Boston, MA 02215, USA
    Health Serv Res 42:611-28. 2007
  7. doi request reprint Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer
    Lisa I Iezzoni
    Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA, USA
    Arch Phys Med Rehabil 89:595-601. 2008
  8. pmc Managed care and cancer outcomes for Medicare beneficiaries with disabilities
    Richard G Roetzheim
    Department of Family Medicine, University of South Florida, 12901 Bruce B Downs Blvd, MDC 13, Tampa, FL 33612, USA
    Am J Manag Care 14:287-96. 2008
  9. ncbi request reprint Drug-associated disease: hematologic dysfunction
    Erik R Vandendries
    Division of Hemostasis Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA
    Crit Care Clin 22:347-55, viii. 2006

Collaborators

  • C C Morton
  • Ellen P McCarthy
  • LISA L IEZZONI
  • Richard G Roetzheim
  • Erik R Vandendries
  • C N Adra
  • Thomas N Chirikos
  • Donglin Li
  • Kristen J Wells
  • Long H Ngo
  • J L Donato
  • H Turner
  • M T Kolker
  • L E Schnipper
  • R Kheraj
  • S Weremowicz
  • R Badovinac
  • C Moran
  • F Syed
  • T Shirakawa
  • H Cai

Detail Information

Publications9

  1. doi request reprint Emerging treatment options for advanced-stage mycosis fungoides
    Reed E Drews
    Beth Israel Deaconess Medical Center, 330 Brookline Ave, E RA 430, Boston, MA 02215
    J Clin Oncol 30:4064-70. 2012
    ..The scalp tumor has overlying epidermal change with ulceration; the face tumor is subdermal with minimal overlying epidermal change and obstructs the right external auditory meatus (Fig 1D). You consider management options...
  2. ncbi request reprint Genetic analysis of adenovirus E1A: induction of genetic instability and altered cell morphologic and growth characteristics are segregatable functions
    R Drews
    Charles A Dana Research Institute and the Harvard Thorndike Laboratory of Beth Israel Deaconess Medical Center, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Mutat Res 421:9-25. 1998
    ....
  3. ncbi request reprint Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients
    Reed E Drews
    Department of Medicine, Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA
    Clin Chest Med 24:607-22. 2003
    ..Because of its anticoagulant effect, however, drotrecogin alfa may induce bleeding. Guidelines for drotrecogin alfa use must take into account bleeding risks...
  4. ncbi request reprint SMARCAD1, a novel human helicase family-defining member associated with genetic instability: cloning, expression, and mapping to 4q22-q23, a band rich in breakpoints and deletion mutants involved in several human diseases
    C N Adra
    Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Genomics 69:162-73. 2000
    ....
  5. pmc Disparities in breast cancer treatment and survival for women with disabilities
    Ellen P McCarthy
    Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Ann Intern Med 145:637-45. 2006
    ..Little is known about breast cancer treatment for women with disabilities...
  6. pmc Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare
    Ellen P McCarthy
    Division of General Medicine and Primary Care, Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, E RO 139, Boston, MA 02215, USA
    Health Serv Res 42:611-28. 2007
    ..To examine stage at diagnosis and survival for disabled Medicare beneficiaries diagnosed with cancer under age 65 and compare their experiences with those of other persons diagnosed under age 65...
  7. doi request reprint Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer
    Lisa I Iezzoni
    Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA, USA
    Arch Phys Med Rehabil 89:595-601. 2008
    ..Treatment disparities for disabled Medicare beneficiaries with stage I non-small cell lung cancer...
  8. pmc Managed care and cancer outcomes for Medicare beneficiaries with disabilities
    Richard G Roetzheim
    Department of Family Medicine, University of South Florida, 12901 Bruce B Downs Blvd, MDC 13, Tampa, FL 33612, USA
    Am J Manag Care 14:287-96. 2008
    ..To determine if the type of insurance arrangement, specifically health maintenance organization (HMO) vs fee-for-service (FFS), affects cancer outcomes for Medicare beneficiaries with disabilities...
  9. ncbi request reprint Drug-associated disease: hematologic dysfunction
    Erik R Vandendries
    Division of Hemostasis Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA
    Crit Care Clin 22:347-55, viii. 2006
    ..For example, cisplatin can cause hemolytic uremia syndrome and erythropoietin deficiency, and quinine can precipitate immune-mediated thrombocytopenia, immune-mediated thrombocytopenia, and thrombotic microangiopathy...